Alex founded Motilent in 2013 to expedite collaborative research in his field of medical image analysis for gastrointestinal (GI) disorders. Since then, Motilent has grown to working across a range of GI specialties in research and has produced it’s first clinically available product for Crohn’s disease monitoring – GIQuant. Alex holds master degrees in Biochemistry and Medical Physics, a PhD in MRI imaging and spent 2 years on the board of an AIM listed UK medical device company.

Russell joined Motilent in September 2017 to establish it as a medical device manufacturer to bring GIQuant to the market as a CE marked product. Russell holds an MEng in Biomaterials Engineering, a PhD in Bionanotechnology and 5 years experience of medical device regulations, quality systems and project management.

Laurence brings a wealth of experience to Motilent working for the past 15 years in medical imaging at some of the most important companies in the space. As CTO, Laurence will help Motilent develop its portfolio of technologies for use in digestive disease and oversee its transition into an ‘at market’ Medical Device company.